References
 
  1. Ritch PS. Treatment of cancer-related hypercalcemia. Semin Oncol. 1990;17(suppl 5):26-33.
  2. Henderson JE, Shustik C, Kremer R, Rabbani SA, Hendy GN, Goltzman D. Circulating concentrations of parathyroid hormone-like peptide in malignancy and in hyperparathyroidism. J Bone Miner Res. 1990;5:105-113.
  3. Chisholm MA, Mulloy AL, Taylor AT. Acute management of cancer-related hypercalcemia. Ann Pharmacother. 1996;30:507-513.
  4. Warrell RP Jr. Metabolic emergencies. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. 6th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2001, pp 2633-2634.
  5. Muggia FM. Overview of cancer-related hypercalcemia: epidemiology and etiology. Semin Oncol 1990;17(2 suppl 5):3-9.
  6. Lang-Kummer J. Hypercalcemia. In: Yarbro CH, Frogge MH, Goodman M, Groenwald SL, eds. Cancer Nursing: Principles and Practice: 4th ed. Sudbury, Mass: Jones and Bartlett Publishers; 1997:684-701.
  7. Nelson KA, Walsh D, Abdullah O, et al. Common complications of advanced cancer. Semin Oncol 2000;27:34-44.
  8. Lamy O, Jenzer-Closuit A, Burckhard P. Hypercalcaemia of malignancy: an undiagnosed and undertreated disease. J Intern Med 2001;250:73-79.
  9. Barnett ML. Hypercalcemia. Semin Oncol Nurs 1999;15:190-201.

  10. Warrell RP Jr, Bockman RS, Coonley CJ, et al. Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia. J Clin Invest 1984;73:1487-1490.
  11. Bockman RS, Repo MA, Warrell RP Jr, et al. Distribution of trace levels of therapeutic gallium in bone as mapped by synchrotron x-ray microscopy. Proc Natl Acad Sci. 1990;87:4149-4153.
  12. Hall TJ, Chambers TJ. Gallium inhibits bone resorption by a direct effect on osteoclasts. Bone Miner. 1990;8:211-216.
  13. Blair HC, Teitelbaum SL, Tan HL, Schlesinger PH. Reversible inhibition of osteoclastic activity by bone-bound gallium (III). J Cell Biochem. 1992;48:401-410.
  14. Bernstein LR. Mechanisms of therapeutic activity for gallium. Pharmacol Rev 1998;50:665-682.
  15. Donnelly R, Bockman RS, Doty SB, et al. Bone particles from gallium-treated rats are resistant to resorption in vivo. Bone Miner 1991;12:167-179.
  16. Bockman RS. Studies on the mechanism of action of gallium nitrate. Semin Oncol. 1991;18(suppl 5):21-25.
  17. Bockman RS, Boskey AL, Blumenthal NC, Alcock NW, Warrell RP Jr. Gallium increases bone calcium and crystallite perfection of hydroxyapatite. Calcif Tissue Int. 1986;39:376-381.
  18. Repo MA, Bockman RS, Betts F, Boskey AL, Alcock NW, Warrell RP Jr. Effect of gallium on bone mineral properties. Calcif Tissue Int. 1988;43:300-306.
  19. Donnelly R, Boskey A. The effect of gallium on seeded hydroxyapatite growth. Calcif Tissue Int 1989;44:138-142.
  20. Blumenthal NC, Cosma V, Levine S. Effect of gallium on the in vitro formation, growth, and solubility of hydroxyapatite. Calcif Tissue Int 1989;45:81-87.
  21. Stern LS, Matkovic V, Weisbrode SE, et al. The effects of gallium nitrate on osteopenia induced by ovariectomy and a low-calcium diet in rats. Bone Miner 1994;25:59-69.
  22. Bockman RS, Guidon PT Jr, Pan LC, Salvatori R, Kawaguchi A. Gallium nitrate increases type I collagen and fibronectin mRNA and collagen protein levels in bone and fibroblast cells. J Cell Biochem 1993;52:396-403.
  23. Warrell RP Jr, Israel R, Frisone M, Snyder T, Gaynor JJ, Bockman RS. Gallium nitrate for acute treatment of cancer-related hypercalcemia: a randomized, double-blind comparison to calcitonin. Ann Intern Med. 1988;108:669-674.
  24. Warrell RP Jr, Skelos A, Alcock NW, Bockman RS. Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicopharmacological and dose response analysis. Cancer Res. 1986;46:4208-4212.
  25. Bajorunas DR: Clinical manifestations of cancer-related hypercalcemia. Semin Oncol 17 (2 Suppl 5): 16-25, 1990.
  26. Mahon SM: Signs and symptoms associated with malignancy-induced hypercalcemia. Cancer Nurs 12 (3): 153-60, 1989.
 
Close Window